Bloomberg
Bill Ackman, the activist investor who has been a staunch defender of Valeant Pharmaceuticals International Inc., trimmed his fund’s holdings of the stock for tax reasons. Ackman’s Pershing Square Capital Management sold about 5 million shares of
Bill Ackman’s Pershing Square Trims Valeant Stake to 8.5%Wall Street Journal
Ackman’s Pershing Square Sold Nearly 5M Shares of Valeant Pharma (VRX) for Tax StreetInsider.com
Pershing Square lightens Valeant stake in tax loss sellingSeeking Alpha
CNBC -Channel News Asia
all 13 news articles …read more

Source: Business